Several studies have shown that the CXCR4/CXCL12 interaction may foster local tumor growth and metastatic potential by maintaining an immune-quiescent microenvironment, which could be blocked by CXCR4 antagonism (134–138). Here, CXCL12 is linked to neoplasm.